On the Insel Campus, home to one of Switzerland’s largest hospital networks, new clinical and engineering collaborations are advancing with clear purpose. Through the Bern MedTech Collaboration Call (BMCC), Inselspital, the University of Bern and CSEM are working together to develop solutions that address real clinical needs while supporting Bern’s ambition to become a leading MedTech innovation hub by 2030.
Funded with 2 million Swiss francs annually by the Canton of Bern, BMCC has approved 35 projects so far, with 8 new ones scheduled to start by 2026. They cover cardiology, pediatrics, oncology, women’s health, neurology, and critical care. Each combines clinical insight, academic expertise, and CSEM’s technology to create diagnostic and monitoring tools that address unmet medical needs.
CSEM plays a key role. Its expertise in sensing technologies, microelectronics, medical wearables, implants, photonics, and artificial intelligence is driving progress across many applications. Current efforts include non-invasive lung-pressure monitoring, improved fetal and maternal tracking, early cancer-spread assessment, real-time brain-signal analysis for seizure control, and strategies to reduce postoperative confusion. Several projects also focus on continuous blood-pressure monitoring (oBPM), using CSEM’s patented technology. This technology was successfully spun out through the company Aktiia, which is powering the Food and Drug Administration (FDA)-approved Hilo wristband monitor on a global scale.
What matters most is that these technologies help clinicians make better decisions and give emerging companies the means to develop viable solutions.
BMCC projects provide early testing environments that help promising ideas grow into viable ventures. VidaSense, for example, emerged from a BMCC-backed project, gained visibility through VentureKick, and is now advancing within CSEM’s ACCELERATE program, which supports teams to turn prototypes into clinic- or industry-ready solutions. “What matters most is that these technologies help clinicians make better decisions and give emerging companies the means to develop viable solutions,” says Josef Hayoz, Senior Manager Medtech Bern, CSEM.
CSEM maintains offices and meeting spaces on the Insel Campus, including facilities within the Sitem StartUp Club. Being close to clinicians, researchers, and start-ups accelerates decision‑making and testing in real workflows, strengthening Bern’s innovation pipeline and reinforcing its growing profile as a national MedTech hub.
Discover how CSEM collaborates with the University of Bern and Insel Group to advance digital health and strengthen Bern’s medtech ecosystem. Or contact us through our form to explore collaboration opportunities.